Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients-Reference-Cited by-同舟云学术

Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients

Published:2010-04 Issue:4 Volume:30 Page:546-553
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Kim Beom Kyung,Kim Do Young,Park Jun Yong,Ahn Sang Hoon,Chon Chae Yoon,Kim Ja Kyung,Paik Yong Han,Lee Kwan Sik,Park Young Nyun,Han Kwang Hyub

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2009.02192.x/fullpdf

Reference44 articles.

1. 1. Lok AS , McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-39.

2. 2. Degertekin B , Lok AS. Indications for therapy in hepatitis B. Hepatology 2009; 49 (Suppl.): S129-37.

3. 3. Liaw YF , Sung JJ , Chow WC , et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-31.

4. 4. de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008; 49: 520-7.

5. 5. Bedossa P , Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol 2009; 50: 1-3.

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring hepatic fibrosis screening via deep learning analysis of tongue images;Journal of Traditional and Complementary Medicine;2024-09

2. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Impact on Fibrosis Risk in Inactive Chronic Hepatitis B Patients: Insights from a Cross-Sectional Study;Journal of Clinical Medicine;2024-08-12

3. The non-invasive serum biomarkers contributes to indicate liver fibrosis staging and evaluate the progress of chronic hepatitis B;BMC Infectious Diseases;2024-06-26

4. Lipoprotein(a) level predicts the development of nonalcoholic fatty liver disease in Korean adults: A retrospective longitudinal study;Medicine;2024-05-31

5. Protocolo de valoración de la fibrosis hepática. Pruebas no invasivas para el diagnóstico de la enfermedad hepática crónica compensada;Medicine - Programa de Formación Médica Continuada Acreditado;2024-05